Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.42 |
| ▸ | POLB | P06746 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | BCHE | P06276 | 2/20 | 0.42 |
| ▸ | PTPRC | P08575 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15705869 | 0.89 | MAPT (0.46) | MAPTGAAMEN1KMT2APOLB | |
| SCHEMBL10053806 | 0.82 | CSNK1G1 (0.47) | MAPTGAAMEN1KMT2APOLB | |
| SCHEMBL6358112 | 0.82 | MAPT (0.50) | MAPTGAALMNAALDH1A1KDM4E | |
| SCHEMBL6279537 | 0.82 | MAPT (0.50) | MAPTGAALMNAALDH1A1KDM4E | |
| SCHEMBL22893207 | 0.80 | MAPT (0.47) | MAPTGAAMEN1KMT2APOLB | |
| SCHEMBL20198694 | 0.80 | MAPT (0.47) | MAPTGAAMEN1KMT2APOLB | |
| SCHEMBL31297139 | 0.79 | TTR (0.49) | MAPTGAAMEN1KMT2APOLB | |
| SCHEMBL2121518 | 0.77 | PGAM1 (0.38) | MAPTGAAMEN1KMT2APOLB | |
| SCHEMBL16478893 | 0.75 | STAT3 (0.38) | MAPTMEN1KMT2APOLBLMNA | |
| SCHEMBL16473097 | 0.75 | MAPT (0.36) | MAPTGAAMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9296901-B2 | Composite particles, and coloring composition and resin composition using the same | TODA KOGYO CORPORATION (JP) | 2016-03-29 | — | — | US | claimed |
| US-20150079008-A1 | FLUORESCENCE PLAQUE-DISCLOSANT FOR DETECTING DENTAL PLAQUE | FLOSS MY HEART, LLC | 2015-03-19 | — | — | US | claimed |
| EP-2099869-B1 | MODIFIED PIGMENTS AND METHODS FOR MAKING AND USING THE SAME | SENSIENT COLORS INC (US) | 2013-05-01 | — | — | EP | claimed |
| US-20100081728-A1 | Mixable and color tone freely reproducible dental coloring material composition, and set and method thereof | KABUSHIKI KAISHA SHOFU | 2010-04-01 | — | — | US | claimed |
| EP-1929304-A2 | CELLULAR OR ORGANELLE-ENTRAPPED NANOPARTICLES | Freedom-2, LLC (US) | 2008-06-11 | — | — | EP | claimed |
| WO-2007024429-A2 | CELLULAR OR ORGANELLE-ENTRAPPED NANOPARTICLES | FREEDOM-2, LLC (US) | 2007-03-01 | — | — | WO | claimed |
| US-20060050946-A1 | Computer-assisted cell analysis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-03-09 | — | — | US | claimed |
| US-6106852-A | Temporary tattoo device and method | DELIQUESCENCE HOLDINGS, INC. (CA) | 2000-08-22 | — | — | US | claimed |
| WO-1999012753-A1 | DEVICE AND METHOD FOR APPLYING A TEMPORARY TATTOO | DELIQUESCENCE HOLDINGS INC. (CA) | 1999-03-18 | — | — | WO | claimed |
| EP-4748891-A1 | RUBBER COMPOSITION | NOK Corporation (JP) | 2026-05-27 | — | — | EP | disclosed |
| US-12558205-B2 | Composition for forming artificial tooth, method of preparing artificial tooth, and artificial tooth prepared thereby | ODS CO., LTD. (KR) | 2026-02-24 | — | — | US | disclosed |
| US-20260048043-A1 | HIGH LOADING ORAL FILM FORMULATION WITH IMPROVED BIOAVAILABILITY | INTELGENX CORP (CA) | 2026-02-19 | — | — | US | disclosed |
| EP-4308135-B1 | THERAPEUTIC USE OF ENGINEERED POSTBIOTICS COMPRISING BACTERIOCINS AND/OR ENDOLYSINS | ELIGO BIOSCIENCE (FR) | 2025-12-03 | — | — | EP | disclosed |
| US-20250216301-A1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING (II) | ESSENLIX CORPORATION (US) | 2025-07-03 | — | — | US | disclosed |
| US-4952401-A | Rodenticide for toxic wick | ICI AMERICAS INC. (US) | 1990-08-28 | — | — | US | disclosed |
| US-4868206-A | LIQUID, HYDROXYCOUMARIN DERIVATIVES | ICI AMERICAS INC. (US) | 1989-09-19 | — | — | US | disclosed |
| US-4855133-A | Composition for attracting flies | EARTH CHEMICAL COMPANY, LIMITED (JP) | 1989-08-08 | — | — | US | disclosed |
| EP-0316054-A1 | Cosmetic containing fine soft microcapsules | SHISEIDO COMPANY LIMITED (JP) | 1989-05-17 | — | — | EP | disclosed |
| EP-0225795-A2 | Composition for rodent control | ICI AMERICAS INC. (US) | 1987-06-16 | — | — | EP | disclosed |
| US-4169169-A | DECALS FOR SKIN, ALCOHOL SOLUBLE DYES | DAI NIPPON INSATSU KABUSHIKI KAISHA (JP) | 1979-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12558205-B2 | Composition for forming artificial tooth, method of preparing artificial tooth, and artificial tooth prepared thereby | PFN1, GPX1, TFAM | MAPT 718/4885GAA 3964/4885MEN1 4628/4885 |
| US-20260048043-A1 | HIGH LOADING ORAL FILM FORMULATION WITH IMPROVED BIOAVAILABILITY | MUC1, TAS2R42, MTX2 | MAPT 2009/4885GAA 3347/4885MEN1 1264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.